175 related articles for article (PubMed ID: 11525275)
1. Renal metastases from thyroid papillary carcinoma: study of sodium iodide symporter expression.
Smallridge RC; Castro MR; Morris JC; Young PR; Reynolds JC; Merino MJ; Sarlis NJ
Thyroid; 2001 Aug; 11(8):795-804. PubMed ID: 11525275
[TBL] [Abstract][Full Text] [Related]
2. Relationship between expression of the sodium/iodide symporter and 131I uptake in recurrent lesions of differentiated thyroid carcinoma.
Min JJ; Chung JK; Lee YJ; Jeong JM; Lee DS; Jang JJ; Lee MC; Cho BY
Eur J Nucl Med; 2001 May; 28(5):639-45. PubMed ID: 11383871
[TBL] [Abstract][Full Text] [Related]
3. Follicular Variant of Papillary Thyroid Cancer with Bilateral Renal Metastases Discovered Incidentally During Work-Up of Primary Endometrial Cancer: A Rare Occurrence.
Lubana SS; Singh N; Tuli SS; Bashir T; Sachmechi I; Kemeny MM
Am J Case Rep; 2015 Jul; 16():459-68. PubMed ID: 26181765
[TBL] [Abstract][Full Text] [Related]
4. Relationship of sodium/iodide symporter expression with I131 whole body scan uptake between primary and metastatic lymph node papillary thyroid carcinomas.
Lee SJ; Choi KC; Han JP; Park YE; Choi MG
J Endocrinol Invest; 2007 Jan; 30(1):28-34. PubMed ID: 17318019
[TBL] [Abstract][Full Text] [Related]
5. Distribution of Na+/I- symporter in thyroid cancers in an iodine-deficient population: an immunohistochemical study.
Mishra A; Pal L; Mishra SK
World J Surg; 2007 Sep; 31(9):1737-1742. PubMed ID: 17653791
[TBL] [Abstract][Full Text] [Related]
6. Tumor-to-tumor metastases: papillary thyroid carcinoma into a clear cell renal cell carcinoma.
Song JS; Taylor SM; Trites J; Rigby MH; Bullock MJ; Merrimen J; Rendon R; Hart RD
J Otolaryngol Head Neck Surg; 2017 Mar; 46(1):17. PubMed ID: 28249616
[TBL] [Abstract][Full Text] [Related]
7. Euthyroid status after total thyroidectomy due to functioning lung metastases from a clear cell variant of papillary thyroid carcinoma.
Lee JI; Chung YJ; Park SJ; Ryu HS; Cho BY
Thyroid; 2012 Oct; 22(10):1084-7. PubMed ID: 22873179
[TBL] [Abstract][Full Text] [Related]
8. Differentiated thyroid carcinoma that express sodium-iodide symporter have a lower risk of recurrence for children and adolescents.
Patel A; Jhiang S; Dogra S; Terrell R; Powers PA; Fenton C; Dinauer CA; Tuttle RM; Francis GL
Pediatr Res; 2002 Nov; 52(5):737-44. PubMed ID: 12409522
[TBL] [Abstract][Full Text] [Related]
9. Adrenal metastasis secondary to papillary thyroid carcinoma.
Koutkia P; Safer JD
Thyroid; 2001 Nov; 11(11):1077-9. PubMed ID: 11762719
[TBL] [Abstract][Full Text] [Related]
10. Unusual case of adrenal and renal metastases from papillary carcinoma of thyroid.
Malhotra G; Upadhye TS; Sridhar E; Asopa RV; Garde PS; Gawde S; Rangarajan V
Clin Nucl Med; 2010 Sep; 35(9):731-6. PubMed ID: 20706057
[TBL] [Abstract][Full Text] [Related]
11. Renal metastases from papillary thyroid carcinoma.
Sardi A; Agnone CM; Pellegrini A
J La State Med Soc; 1992 Sep; 144(9):416-20. PubMed ID: 1402321
[TBL] [Abstract][Full Text] [Related]
12. Renal Metastasis From Primary Thyroid Cancer on 131I and MRI Imaging.
Patel DR; Kamat BH; Farwell MD
Clin Nucl Med; 2017 Jan; 42(1):70-72. PubMed ID: 27846002
[TBL] [Abstract][Full Text] [Related]
13. Two patients with highly aggressive macrofollicular variant of papillary thyroid carcinoma.
Cardenas MG; Kini S; Wisgerhof M
Thyroid; 2009 Apr; 19(4):413-6. PubMed ID: 19355832
[TBL] [Abstract][Full Text] [Related]
14. Papillary thyroid carcinoma presenting as a primary renal tumor with multiple pulmonary and bone metastases: a case report.
Gezer E; Selek A; Tarkun İ; Cantürk Z; Çetinarslan B
J Med Case Rep; 2019 Apr; 13(1):95. PubMed ID: 31003598
[TBL] [Abstract][Full Text] [Related]
15. Reinduction of cell differentiation and 131I uptake in a poorly differentiated thyroid tumor in response to the reverse transcriptase (RT) inhibitor nevirapine.
Modoni S; Landriscina M; Fabiano A; Fersini A; Urbano N; Ambrosi A; Cignarelli M
Cancer Biother Radiopharm; 2007 Apr; 22(2):289-95. PubMed ID: 17600478
[TBL] [Abstract][Full Text] [Related]
16. Expression of sodium-iodide symporter and TSH receptor in subclinical metastatic lymph nodes of papillary thyroid microcarcinoma.
So YK; Son YI; Baek CH; Jeong HS; Chung MK; Ko YH
Ann Surg Oncol; 2012 Mar; 19(3):990-5. PubMed ID: 21879263
[TBL] [Abstract][Full Text] [Related]
17. [Seven cases of brain metastasis from papillary thyroid carcinoma].
Ikekubo K; Hino M; Ito H; Hirao K; Ueshima M; Tanaka T; Kobayashi H; Ishihara T; Kurahachi H
Kaku Igaku; 2000 Jul; 37(4):349-57. PubMed ID: 10965656
[TBL] [Abstract][Full Text] [Related]
18. Sodium-iodide symporter (NIS) gene expression in lymph-node metastases of papillary thyroid carcinomas.
Arturi F; Russo D; Giuffrida D; Schlumberger M; Filetti S
Eur J Endocrinol; 2000 Nov; 143(5):623-7. PubMed ID: 11078986
[TBL] [Abstract][Full Text] [Related]
19. Low expression of sodium iodide symporter expression in aggressive variants of papillary thyroid carcinoma.
Wei S; Gao M; Zhao C; Pan Y; Li H; Li J; Li X
Int J Clin Oncol; 2014 Oct; 19(5):800-4. PubMed ID: 24096868
[TBL] [Abstract][Full Text] [Related]
20. Iodide symporter gene expression in human thyroid tumors.
Arturi F; Russo D; Schlumberger M; du Villard JA; Caillou B; Vigneri P; Wicker R; Chiefari E; Suarez HG; Filetti S
J Clin Endocrinol Metab; 1998 Jul; 83(7):2493-6. PubMed ID: 9661633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
